Strathspey Crown Holdings Group LLC 13D and 13G filings for AEON Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-08-22 4:37 pm Sale | 2023-08-11 | 13D | AEON Biopharma, Inc. AEON | Strathspey Crown Holdings Group LLC | 2,031,773 5.470% | -7,388,597 (-78.43%) | Filing |
| 2023-07-31 4:45 pm Purchase | 2023-07-21 | 13D | AEON Biopharma, Inc. AEON | Strathspey Crown Holdings Group LLC | 9,420,370 25.400% | 9,420,370 (New Position) | Filing |